Unió Europea - francès - EMA (European Medicines Agency)

teva b.v.  - le témozolomide - glioma; glioblastoma - agents antinéoplasiques - pour le traitement des patients adultes atteints de glioblastome multiforme nouvellement diagnostiqué concomitamment à la radiothérapie (rt) et par la suite en monothérapie. pour le traitement des enfants dès l'âge de trois ans, les adolescents et les adultes atteints de gliome malin, tel que glioblastome multiforme ou astrocytome anaplasique, montrant une récidive ou une progression après un traitement standard.

Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - temozolomidum - capsules - temozolomidum 5 mg, lactosum 132.8 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, kapselhülle: natrii laurilsulfas, gelatina, e 171, e 132, e 172 (flavum), drucktinte: lacca, aqua purificata, ammonii hydroxidum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.33 mg. - cytostatique - synthetika

Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - temozolomidum - capsules - temozolomidum 20 mg, lactosum 182.2 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, kapselhülle: natrii laurilsulfas, gelatina, e 171, e 172 (flavum), drucktinte: lacca, aqua purificata, ammonii hydroxidum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.47 mg. - cytostatique - synthetika

Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - temozolomidum - capsules - temozolomidum 100 mg, lactosum 175.7 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, kapselhülle: natrii laurilsulfas, gelatina, e 171, e 172 (rubrum), drucktinte: lacca, aqua purificata, ammonii hydroxidum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.64 mg. - cytostatique - synthetika

Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - temozolomidum - capsules - temozolomidum 250 mg, lactosum 154.3 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, kapselhülle: natrii laurilsulfas, gelatina, e 171, drucktinte: lacca, aqua purificata, ammonii hydroxidum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.96 mg. - cytostatique - synthetika

Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - temozolomidum - capsules - temozolomidum 140 mg, lactosum 246 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, kapselhülle: natrii laurilsulfas, gelatina, e 171, e 132, drucktinte: lacca, aqua purificata, ammonii hydroxidum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 0.89 mg. - cytostatique - synthetika

Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

msd merck sharp & dohme ag - temozolomidum - capsules - temozolomidum 180 mg, lactosum 316.3 mg, carboxymethylamylum natricum a, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, kapselhülle: natrii laurilsulfas, gelatina, e 171, e 172 (flavum), e 172 (rubrum), drucktinte: lacca, aqua purificata, ammonii hydroxidum, kalii hydroxidum, e 172 (nigrum), pro capsula corresp. natrium 1.14 mg. - cytostatique - synthetika

Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - temozolomidum, ammonii hydroxidum - capsules - temozolomidum 5 mg, lactosum 87.3 mg, carboxymethylamylum natricum a corresp. natrium 0.21 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, ammonii hydroxidum, e 171, e 172 (flavum), e 132, pro capsula. - cytostatique - synthetika

Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - temozolomidum, ammonii hydroxidum - capsules - temozolomidum 20 mg, lactosum 72.3 mg, carboxymethylamylum natricum a corresp. natrium 0.21 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, ammonii hydroxidum, e 171, e 110, pro capsula. - cytostatique - synthetika

Suïssa - francès - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - temozolomidum, ammonii hydroxidum - capsules - temozolomidum 100 mg, lactosum 83.6 mg, carboxymethylamylum natricum a corresp. natrium 0.42 mg, silica colloidalis anhydrica, acidum tartaricum, acidum stearicum, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, ammonii hydroxidum, kalii hydroxidum, e 172 (rubrum), e 172 (flavum), e 171, pro capsula. - cytostatique - synthetika